Bank of New York Mellon’s Kindred Biosciences, Inc. KIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-21,058
Closed -$194K 4584
2021
Q2
$194K Sell
21,058
-109,653
-84% -$1.01M ﹤0.01% 4104
2021
Q1
$650K Sell
130,711
-119
-0.1% -$592 ﹤0.01% 3547
2020
Q4
$564K Sell
130,830
-7,172
-5% -$30.9K ﹤0.01% 3561
2020
Q3
$592K Sell
138,002
-9,972
-7% -$42.8K ﹤0.01% 3407
2020
Q2
$665K Buy
147,974
+16,904
+13% +$76K ﹤0.01% 3323
2020
Q1
$525K Buy
131,070
+17,323
+15% +$69.4K ﹤0.01% 3336
2019
Q4
$965K Buy
113,747
+3,684
+3% +$31.3K ﹤0.01% 3263
2019
Q3
$754K Sell
110,063
-2,396
-2% -$16.4K ﹤0.01% 3322
2019
Q2
$936K Buy
112,459
+1,545
+1% +$12.9K ﹤0.01% 3258
2019
Q1
$1.02M Buy
110,914
+9,545
+9% +$87.6K ﹤0.01% 3166
2018
Q4
$1.11M Buy
101,369
+10,522
+12% +$115K ﹤0.01% 3046
2018
Q3
$1.27M Buy
90,847
+17,798
+24% +$248K ﹤0.01% 3120
2018
Q2
$778K Sell
73,049
-15,114
-17% -$161K ﹤0.01% 3389
2018
Q1
$762K Buy
88,163
+4,620
+6% +$39.9K ﹤0.01% 3347
2017
Q4
$789K Buy
83,543
+8,995
+12% +$85K ﹤0.01% 3372
2017
Q3
$586K Buy
74,548
+11,081
+17% +$87.1K ﹤0.01% 3509
2017
Q2
$546K Buy
+63,467
New +$546K ﹤0.01% 3563
2015
Q2
Sell
-39,466
Closed -$282K 4290
2015
Q1
$282K Sell
39,466
-73
-0.2% -$522 ﹤0.01% 3799
2014
Q4
$295K Sell
39,539
-716
-2% -$5.34K ﹤0.01% 3783
2014
Q3
$372K Sell
40,255
-95
-0.2% -$878 ﹤0.01% 3713
2014
Q2
$753K Buy
40,350
+18,413
+84% +$344K ﹤0.01% 3464
2014
Q1
$407K Buy
+21,937
New +$407K ﹤0.01% 3637